Thom Do

This study evaluates cipargamin's efficacy against Babesia species and identifies resistance mechanisms, showing its effectiveness as an anti-babesial drug but limitations due to resistance, with combination therapy with tafenoquine offering potential.

This study molecularly detects pathogens in ticks and fleas from companion dogs and cats in East and Southeast Asia, finding high prevalence of zoonotic vector-borne pathogens.